BERTRAND VELGE

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

LifeMD, Inc.

Filing Date Source Excerpt
2019-12-16 Bertrand Velge 2,173,914 shares beneficially owned No specific role or committees mentioned in the filing.
2020-12-07 Bertrand Velge The following Director Compensation Table sets forth information concerning compensation for services rendered to our independent directors for the fiscal year ended December 31, 2019: Bertrand Velge - - - - - - - -
2021-05-12 Bertrand Velge – Director On June 10, 2019, Mr. Velge was appointed to the Board of Directors. Mr. Velge is the Managing Director of Graftyset, Ltd., a privately held company based in the United Kingdom. Mr. Velge is also a member of the Board of Directors of Quantum Computing Inc. a public company. Graftyset is a wholesale distributor of wine, beer and other alcoholic and non-alcoholic beverage, based in Sidcup, Kent (UK). Mr. Velge has served as Managing Director since the company was incorporated in 2003 under the name of Otterden Vintners, Ltd. Mr. Velge also served as Director for Aliunde Ltd. since 2005. Mr. Velge has over twenty years of experience in multi-disciplinary venture investing and was managing director and co-founder of a fund that trades equities in Europe, Asia and the US focusing on IPOs. He speaks English, Flemish and French, and is a graduate of the Universite Catholique de Louvain.
2022-04-29 Velge Director Agreement\nOn December 30, 2021, the Company and Mr. Velge entered into a renewed director agreement, whereby, as compensation for his services as a member of the Board, Mr. Velge shall receive 8,000 restricted stock units, vesting quarterly as follows: (i) 4,000 restricted stock units for the first two quarters of service vesting on December 31, 2021, (ii) 2,000 restricted stock units for the third quarter of service vesting on March 31, 2022, and (iii) the final 2,000 restricted stock units vesting on June 16, 2022.
2023-04-28 Velge Director Agreement On November 22, 2022, the Company and Mr. Velge entered into a second renewed director agreement, whereby, as compensation for his services as a member of the Board, Mr. Velge shall receive 8,000 restricted shares, vesting quarterly as follows: (i) 4,000 restricted shares for the first two quarters of service vested on December 31, 2022, (ii) 2,000 restricted shares for the third quarter of service vest on March 31, 2023, and (iii) the final 2,000 restricted shares vest on the earlier of the annual stockholders’ meeting or June 30, 2023.

Data sourced from SEC filings. Last updated: 2026-02-03